D. Karussis

发表

Inhibition of Effector Function but Not T Cell Activation and Increase in FoxP3 Expression in T Cells Differentiated in the Presence of PP14

Zohar Ochanuna, Anat Geiger-Maor, Adi Dembinsky-Vaknin, 2010, PloS one.

Oral administration of the oxidant-scavenger N-acetyl-l-cysteine inhibits acute experimental autoimmune encephalomyelitis

E. Shezen, D. Karussis, D. Lehmann, 1994, Journal of Neuroimmunology.

Cognitive dysfunction following thalamic stroke: a study of 16 cases and review of the literature

D. Karussis, O. Abramsky, Dimitrios Karussis, 2000, Journal of the Neurological Sciences.

The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review.

D. Karussis, Dimitrios Karussis, 2014, Journal of autoimmunity.

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Margaret Burnett, Gavin Giovannoni, 2018, The Lancet.

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

D. Arnold, S. Muley, P. Vermersch, 2018, The Lancet Neurology.

Multiple sclerosis vs Lyme disease: A case presentation to a discussant and a review of the literature

H. Weiner, D. Karussis, O. Abramsky, 1999, Multiple sclerosis.

Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide).

D. Karussis, D. Lehmann, H. Ovadia, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Hematopoietic stem cell transplantation in multiple sclerosis: experimental evidence to rethink the procedures

D. Karussis, S. Slavin, 2004, Journal of the Neurological Sciences.

Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation.

A. Ben-nun, D. Karussis, D. Lehmann, 1992, Journal of immunology.

Chronic-relapsing experimental autoimmune encephalomyelitis (CR-EAE): treatment and induction of tolerance, with high dose cyclophosphamide followed by syngeneic bone marrow transplantation

A. Ben-nun, D. Karussis, D. Lehmann, 1992, Journal of Neuroimmunology.

Bone marrow mesenchymal stem cells: agents of immunomodulation and neuroprotection.

D. Karussis, I. Kassis, A. Vaknin-Dembinsky, 2011, Current stem cell research & therapy.

Increased thrombin inhibition in experimental autoimmune encephalomyelitis

D. Gurwitz, J. Chapman, A. Korczyn, 2005, Journal of neuroscience research.

Vision and Vision-Related Measures in Progressive Multiple Sclerosis

N. Raz, F. Paul, Rebecca Jost, 2019, Front. Neurol..

Therapy with mesenchymal stem cell transplantation in multiple sclerosis is ready for prime time: YES

D. Karussis, I. Kassis, P. Petrou, 2022, Multiple sclerosis.

Increased occurrence of anti-AQP4 seropositivity and unique HLA Class II associations with neuromyelitis optica (NMO), among Muslim Arabs in Israel

T. Ben-Hur, D. Karussis, M. Mandel, 2016, Journal of Neuroimmunology.

Effects of Mesenchymal Stem Cell Transplantation on Cerebrospinal Fluid Biomarkers in Progressive Multiple Sclerosis

D. Karussis, I. Kassis, P. Petrou, 2022, Stem cells translational medicine.

Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein.

D. Karussis, O. Touloumi, N. Grigoriadis, 2006, Archives of neurology.

Linomide induces apoptotic death of cortical CD4/CD8 double positive thymocytes and thymic atrophy by a corticosteroid-independent pathway.

D. Karussis, H. Ovadia, O. Abramsky, 1999, Clinical immunology.

Natural course and pathogenesis of transient focal neurologic symptoms during pregnancy.

T. Ben-Hur, D. Karussis, O. Abramsky, 2008, Archives of neurology.

T-cell responses to distinct AQP4 peptides in patients with neuromyelitis optica (NMO).

T. Ben-Hur, D. Karussis, H. Ovadia, 2016, Multiple sclerosis and related disorders.

CD44 variant DNA vaccination with virtual lymph node ameliorates experimental autoimmune encephalomyelitis through the induction of apoptosis

D. Karussis, N. Grigoriadis, O. Abramsky, 2007, Journal of the Neurological Sciences.

Intraventricular transplantation of neural precursor cell spheres attenuates acute experimental allergic encephalomyelitis

T. Ben-Hur, D. Karussis, N. Grigoriadis, 2003, Molecular and Cellular Neuroscience.

The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group

H. Atkins, A. Bar-Or, M. Freedman, 2010, Multiple sclerosis.

Linomide downregulates autoimmunity through induction of TH2 cytokine production by lymphocytes.

D. Karussis, H. Ovadia, O. Abramsky, 1999, Immunology letters.

Is the routine use of intravenous immunoglobulin treatment in neurologic disorders justified? No.

D. Karussis, O. Abramsky, 1999, Archives of neurology.

Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials.

E. Melamed, T. Ben-Hur, D. Offen, 2016, JAMA neurology.

Safety and Clinical Effects ofMesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in PatientsWith Amyotrophic Lateral Sclerosis Results of Phase 1 / 2 and 2 a Clinical Trials

T. Ben-Hur, D. Offen, D. Karussis, 2016 .

The potential use of adult stem cells for the treatment of multiple sclerosis and other neurodegenerative disorders

D. Karussis, S. Slavin, B. G. Kurkalli, 2008, Clinical Neurology and Neurosurgery.

Immunomodulation of autoimmunity in MRL/lpr mice with syngeneic bone marrow transplantation (SBMT)

A. Ben-nun, D. Karussis, D. Lehmann, 1995, Clinical and experimental immunology.

Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis.

T. Ben-Hur, D. Karussis, N. Grigoriadis, 2008, Archives of neurology.

Synergistic neuroprotective effects of Fingolimod and Mesenchymal Stem Cells (MSC) in Experimental Autoimmune Encephalomyelitis.

D. Karussis, I. Kassis, P. Petrou, 2021, Immunology letters.

CLINICAL TRIAL Beneficial effects of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis

N. Levin, D. Karussis, O. Abramsky, 2021 .

Beneficial effects of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis.

F. Paul, N. Levin, D. Karussis, 2020, Brain : a journal of neurology.

Severe skin reaction related to mycophenolate mofetil for myasthenia gravis.

N. Levin, D. Karussis, Alexander Mali, 2005, Clinical neuropharmacology.

Amelioration of experimental colitis by Copaxone is associated with class-II-restricted CD4 immune blocking.

D. Karussis, Y. Ilan, R. Safadi, 2006, Clinical immunology.

Effects of supermagnetic iron oxide labeling on the major functional properties of human mesenchymal stem cells from multiple sclerosis patients.

J. Bulte, D. Karussis, I. Kassis, 2010, International journal of stem cells.

Worldwide status of clinical experimentation with stem cells in neurologic diseases

D. Karussis, 2012, Neurology.

Immunosuppressive and Immunomodulating Therapeutic Approaches for Induction of Self-Tolerance in Experimental Autoimmune Encephalomyelitis (EAE and CR-EAE) and Multiple Sclerosis

D. Karussis, O. Abramsky, 1999 .

Myasthenia gravis-associated neuromyelitis optica-like disease: an immunological link between the central nervous system and muscle?

T. Ben-Hur, D. Karussis, O. Abramsky, 2011, Archives of neurology.

Inhibition of acute, experimental autoimmune encephalomyelitis by the synthetic immunomodulator linomide

A. Ben-nun, D. Karussis, D. Lehmann, 1993, Annals of neurology.

Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation.

A. Ben-nun, D. Karussis, D. Lehmann, 1993, The Journal of clinical investigation.

Diagnosis and classification of optic neuritis

G. Plant, L. Leocani, P. Calabresi, 2022, The Lancet Neurology.

Influence of progesterone and clomiphene on Tolosa–Hunt syndrome

N. Levin, D. Karussis, 2002, Neurology.

Linomide activates the adrenocortical axis in the rat: inhibition of experimental autoimmune encephalomyelitis by linomide is not related to the increase of corticosterone

D. Karussis, D. Lehmann, H. Ovadia, 1997, Journal of Neuroimmunology.

Neuralized mesenchymal stem cells (NMSC) exhibit phenotypical, and biological evidence of neuronal transdifferentiation and suppress EAE more effectively than unmodified MSC.

D. Karussis, I. Kassis, P. Petrou, 2019, Immunology letters.

NMO-IgG and AQP4 Peptide Can Induce Aggravation of EAMG and Immune-Mediated Muscle Weakness

D. Karussis, O. Abramsky, Y. Nevo, 2018, Journal of immunology research.

Immunomodulation of autoimmunity by linomide: inhibition of antigen presentation through down regulation of macrophage activity in the model of experimental autoimmune encephalomyelitis

E. Shezen, D. Karussis, D. Lehmann, 1997, Journal of Neuroimmunology.

T Cell Vaccination Benefits Relapsing Progressive Multiple Sclerosis Patients: A Randomized, Double-Blind Clinical Trial

M. Filippi, I. Cohen, H. Atlan, 2012, PloS one.

Cell Vaccination Benefits Relapsing Progressive Multiple Sclerosis Patients : A Randomized , Double-Blind Clinical Trial

M. Filippi, I. Cohen, H. Atlan, 2012 .

Preferential increase of B-cell activating factor in the cerebrospinal fluid of neuromyelitis optica in a white population

D. Karussis, O. Abramsky, A. Vaknin-Dembinsky, 2010, Multiple sclerosis.

Cerebrospinal Fluid (CSF) Exchange Therapy with Artificial CSF Enriched with Mesenchymal Stem Cell Secretions Ameliorates Cognitive Deficits and Brain Pathology in Alzheimer's Disease Mice.

S. Benhamron, D. Karussis, M. Valitsky, 2020, Journal of Alzheimer's disease : JAD.

Cerebrospinal Fluid (CSF) Exchange with Artificial CSF Enriched with Mesenchymal Stem Cell Secretions Ameliorates Experimental Autoimmune Encephalomyelitis

S. Benhamron, D. Karussis, O. Abramsky, 2019, International journal of molecular sciences.

A case report of unilateral cervical lymphadenopathy and multiple cranial neuropathies following mRNA-COVID-19 vaccination

D. Karussis, A. Lossos, Fatma Shalabi, 2022, BMC Neurology.

Humoral and Cellular Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients with Multiple Sclerosis: An Israeli Multi-Center Experience Following 3 Vaccine Doses

E. Staun-ram, D. Karussis, A. Karni, 2022, Frontiers in Immunology.

Delineation of tissue damage mechanisms in experimental autoimmune encephalomyelitis (EAE). I. Cell detachment and lysis induced by encephalitogenic CD4+ T lymphocytes.

A. Ben-nun, H. Wekerle, D. Karussis, 1992, Journal of autoimmunity.

Inhibition of experimental autoimmune neuritis by the immunomodulator linomide.

D. Karussis, H. Ovadia, O. Abramsky, 1998, Immunology letters.

Rare combination of myasthenia and motor neuronopathy, responsive to Msc‐Ntf stem cell therapy

E. Melamed, T. Ben-Hur, D. Offen, 2014, Muscle & nerve.

Enhancement of GVL effect with rhIL-2 following BMT in a murine model for acute myeloid leukemia in SJL/J mice.

D. Karussis, S. Slavin, A. Ackerstein, 1995, Experimental hematology.

T-cell reactivity against AQP4 in neuromyelitis optica

T. Ben-Hur, D. Karussis, H. Ovadia, 2012, Neurology.

Glatiramer Acetate Depot (extended-release) Phase IIa one-year study in patients with Relapsing-remitting Multiple Sclerosis: Safety, tolerability and efficacy – NEDA Analysis (P6.359)

J. Chapman, Ariel Miller, D. Karussis, 2018 .

Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): A proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases

D. Karussis, S. Slavin, I. Kassis, 2008, Journal of the Neurological Sciences.

Multiple Sclerosis

D. Karussis, 2016, International Encyclopedia of Public Health.

Immunotherapy of Multiple Sclerosis

D. Karussis, 2013, BioDrugs.

Immunomodulation of experimental autoimmune myasthenia gravis with linomide

D. Karussis, D. Lehmann, O. Abramsky, 1994, Journal of Neuroimmunology.

A recommended treatment algorithm in relapsing multiple sclerosis: report of an international consensus meeting

F. Fazekas, M. Freedman, Aaron E Miller, 2006, European journal of neurology.

A phase II clinical trial with repeated intrathecal injections of autologous mesenchymal stem cells in patients with amyotrophic lateral sclerosis.

D. Karussis, I. Kassis, P. Petrou, 2021, Frontiers in bioscience.

Immune reconstitution therapy (IRT) in multiple sclerosis: the rationale

D. Karussis, P. Petrou, 2018, Immunologic Research.

Sex-specific prediction of interferon beta therapy response in relapsing-remitting multiple sclerosis

D. Karussis, I. Lavon, Allison Benis, 2015, Journal of Clinical Neuroscience.

The spectrum of post-vaccination inflammatory CNS demyelinating syndromes.

D. Karussis, P. Petrou, 2014, Autoimmunity reviews.

Hematopoietic stem cell transplantation in multiple sclerosis

D. Karussis, U. Vourka-Karussis, I. Kassis, 2013, Expert review of neurotherapeutics.

Neuroinflammation in multiple sclerosis: Evidence for autoimmune dysregulation, not simple autoimmune reaction

D. Karussis, N. Grigoriadis, S. Grigoriadis, 2006, Clinical Neurology and Neurosurgery.

The Frequency of Multiple Sclerosis in Jewish and Arab Populations in Greater Jerusalem

D. Karussis, O. Abramsky, A. Karni, 2003, Neuroepidemiology.

Clinical experience with stem cells and other cell therapies in neurological diseases

D. Karussis, I. Kassis, P. Petrou, 2013, Journal of the Neurological Sciences.

Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis.

Jeff W M Bulte, Panayiota Petrou, J. Bulte, 2010, Archives of neurology.

The potential use of stem cells in multiple sclerosis: An overview of the preclinical experience

D. Karussis, I. Kassis, 2008, Clinical Neurology and Neurosurgery.

Parkinson's disease associated with myasthenia gravis

N. Levin, D. Karussis, O. Abramsky, 2003, Journal of Neurology.

Multiple sclerosis in diverse populations: characteristics in distinct Arab ethnicities in Israel

I. Lavi, Ariel Miller, D. Karussis, 2012, Multiple sclerosis.

The Ras-pathway inhibitor, S-trans-trans-farnesylthiosalicylic acid, suppresses experimental allergic encephalomyelitis

Y. Kloog, D. Karussis, N. Grigoriadis, 2001, Journal of Neuroimmunology.

Extrathymic malignancies in patients with myasthenia gravis

N. Levin, D. Karussis, O. Abramsky, 2005, Journal of the Neurological Sciences.

Acute Disseminated Encephalomyelitis: Idiopathic, Post‐infectious, and Post‐vaccination

D. Karussis, P. Petrou, 2015 .

Familial Mediterranean fever (FMF) and multiple sclerosis: an association study in one of the world’s largest FMF cohorts

E. Ben-Chetrit, D. Karussis, G. Yahalom, 2011, European journal of neurology.

Immune reconstitution therapy (IRT) in multiple sclerosis: the rationale

D. Karussis, P. Petrou, 2018, Immunologic Research.

Cell-based therapeutic strategies for multiple sclerosis

Jeffrey A. Cohen, H. Atkins, S. Reingold, 2017, Brain : a journal of neurology.

CD44 Involvement in Autoimmune Inflammations

E. Turley, D. Karussis, Y. Zick, 2007, Annals of the New York Academy of Sciences.

Stem Cells in Multiple Sclerosis

D. Karussis, I. Kassis, P. Petrou, 2016 .

Use of stem cells for the treatment of multiple sclerosis

D. Karussis, I. Kassis, 2007, Expert review of neurotherapeutics.

Antimyelin-Associated Glycoprotein, Antimyelin Basic Protein, and Antiproteolipid Autoantibodies in Neurologic Diseases

D. Karussis, A. Vaknin-Dembinsky, P. Petrou, 2014 .

Lack of apolipoprotein-E exacerbates experimental allergic encephalomyelitis

D. Michaelson, D. Karussis, N. Grigoriadis, 2003, Multiple sclerosis.

Acute/relapsing experimental autoimmune encephalomyelitis: Induction of long lasting, antigen-specific tolerance by syngeneic bone marrow transplantation

D. Karussis, O. Abramsky, U. Vourka-Karussis, 1999, Multiple sclerosis.

Guidelines for autologous blood and marrow stem cell transplantation in multiple sclerosis: a consensus report written on behalf of the European Group for Blood and Marrow Transplantation and the European Charcot Foundation

M. Filippi, L. Kappos, F. Fazekas, 2000, Journal of Neurology.

Mesenchymal stem cells (MSC) derived from mice with experimental autoimmune encephalomyelitis (EAE) suppress EAE and have similar biological properties with MSC from healthy donors.

D. Karussis, I. Kassis, P. Petrou, 2013, Immunology letters.

Transplanted neural precursor cells reduce brain inflammation to attenuate chronic experimental autoimmune encephalomyelitis

T. Ben-Hur, D. Karussis, N. Grigoriadis, 2006, Experimental Neurology.

Mesenchymal stem cells in neurological diseases

D. Karussis, I. Kassis, A. Vaknin-Dembinsky, 2013 .

Treatment of secondary progressive multiple sclerosis with the immunomodulator linomide

Z. Meiner, D. Karussis, D. Lehmann, 1996, Neurology.

A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: Do they represent a new nosological entity?

D. Karussis, O. Abramsky, R. Leker, 1998, Annals of neurology.

Transplanted multipotential neural precursor cells migrate into the inflamed white matter in response to experimental autoimmune encephalomyelitis

T. Ben-Hur, D. Karussis, O. Abramsky, 2003, Glia.

Repeated immunization of mice with phosphorylated-tau peptides causes neuroinflammation

D. Karussis, N. Grigoriadis, O. Abramsky, 2013, Experimental Neurology.

Increased KPI containing amyloid precursor protein in experimental autoimmune encephalomyelitis brains

D. Gurwitz, J. Chapman, A. Korczyn, 2007, Neuroreport.

[MULTIPLE SCLEROSIS THERAPY - 2019].

D. Karussis, R. Milo, 2019, Harefuah.

Immunomodulation with linomide: possible novel therapy for multiple sclerosis

D. Karussis, D. Lehmann, O. Abramsky, 1996, Multiple sclerosis.

Parkinson's disease associated with myasthenia gravis. A report of 4 cases.

N. Levin, D. Karussis, O. Abramsky, 2003, Journal of Neurology.

Immunomodulating therapeutic approaches for multiple sclerosis

D. Karussis, O. Abramsky, 1998, Journal of the Neurological Sciences.

Inhibition of the progression of multiple sclerosis by linomide is associated with upregulation of CD4+/CD45RA+ cells and downregulation of CD4+/CD45RO+ cells.

D. Karussis, D. Lehmann, O. Abramsky, 1997, Clinical immunology and immunopathology.

The effects of APOE genotype on age at onset and progression of neurodegenerative diseases

D. Michaelson, J. Chapman, A. Korczyn, 2001, Neurology.

The Second Greek-Israeli Symposium on Autoimmunity and Rheumatology: Success Through Synergy.

G. Kitas, D. Rimar, Y. Shoenfeld, 2019, The Israel Medical Association journal : IMAJ.

Neuroprotection in multiple sclerosis

D. Karussis, N. Grigoriadis, O. Abramsky, 2006, Clinical Neurology and Neurosurgery.

Axonal damage in multiple sclerosis: a complex issue in a complex disease

Ioannis Milonas, T. Ben-Hur, D. Karussis, 2004, Clinical Neurology and Neurosurgery.

Long-Term Clinical and Immunological Effects of Repeated Mesenchymal Stem Cell Injections in Patients With Progressive Forms of Multiple Sclerosis

D. Karussis, O. Abramsky, I. Kassis, 2021, Frontiers in Neurology.

Characterization of human sporadic ALS biomarkers in the familial ALS transgenic mSOD1(G93A) mouse model.

Noga Gershoni-Emek, Eran Perlson, Leonardo J Solmesky, 2013, Human molecular genetics.

Clinical Efficacy of Plasma-Exchange in Patients with Progressive forms of Multiple Sclerosis and NMO-Spectrum Disease

T. Ben-Hur, D. Karussis, O. Abramsky, 2016 .

Application of diagnostic criteria for optic neuritis – Authors' reply

G. Plant, L. Leocani, P. Calabresi, 2023, Lancet Neurology.

Increased anti-KIR4.1 antibodies in multiple sclerosis: Could it be a marker of disease relapse?

T. Ben-Hur, D. Karussis, H. Ovadia, 2015, Multiple sclerosis.

Anatomical and functional visual network patterns in progressive multiple sclerosis

N. Levin, D. Karussis, Y. Backner, 2021, Human brain mapping.

How Safe Could Intrathecal Transplantation of Mesenchymal Stem Cells Be Considered in Multiple Sclerosis?—Reply

D. Karussis, O. Abramsky, I. Kassis, 2011 .

Conduction delays in the visual pathways of progressive multiple sclerosis patients covary with brain structure

F. Paul, A. Mezer, N. Levin, 2020, NeuroImage.

Development of a Novel Backbone Cyclic Peptide Inhibitor of the Innate Immune TLR/IL1R Signaling Protein MyD88

D. Karussis, C. Gilon, A. Hoffman, 2018, Scientific Reports.

Immunotherapy of Multiple Sclerosis

D. Karussis, 2013, BioDrugs.

Integrating an evidence-based assessment of benefit and risk in disease-modifying treatment of multiple sclerosis

D. Goodin, E. Havrdová, K. Selmaj, 2007, Current medical research and opinion.

Seronegative neuromyelitis optica: improvement following lymphocytapheresis treatment

Z. Meiner, D. Karussis, N. Hiller, 2008, Multiple sclerosis.

Hematopoietic stem cell transplantation in multiple sclerosis: a review of the clinical experience and a report of an international meeting

D. Karussis, A. Vaknin-Dembinsky, 2010, Expert review of clinical immunology.

Pediatric demyelinating diseases: multiple sclerosis or not?

D. Karussis, A. Vaknin-Dembinsky, 2012, The Israel Medical Association journal : IMAJ.

Immunomodulation of autoimmunity by linomide.

D. Karussis, D. Lehmann, H. Ovadia, 1995, Israel journal of medical sciences.

Response to letter from Dr Hongliang Zhang entitled ‘B-cell activating factor in the cerebrospinal fluid of neuromyelitis optica and multiple sclerosis’

D. Karussis, A. Vaknin-Dembinsky, 2011, Multiple sclerosis.

Low-Density Lipoprotein Receptor-Related Protein 4-Positive Myasthenia Gravis in a Double-Seronegative, Electromyography-Negative Patient.

D. Karussis, P. Zisimopoulou, J. Kruger, 2017, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

Development of a Novel Backbone Cyclic Peptide Inhibitor of the Innate Immune TLR/IL1R Signaling Protein MyD88

D. Karussis, C. Gilon, A. Hoffman, 2018, Scientific Reports.

Delayed-onset flaccid paralysis related to west Nile virus reactivation following treatment with rituximab: a case report

D. Karussis, A. Honig, 2014, BMC Research Notes.

Tumefactive demyelination following in vitro fertilization (IVF)

D. Karussis, O. Abramsky, G. Rosenthal, 2015, Journal of the Neurological Sciences.

Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis.

T. Ben-Hur, D. Karussis, N. Grigoriadis, 2008, Archives of Neurology.

Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis.

J. Bulte, J. Gomori, T. Ben-Hur, 2010, Archives of neurology.

The potential use of stem cells in multiple sclerosis: An overview of the preclinical experience

D. Karussis, I. Kassis, 2008, Clinical Neurology and Neurosurgery.

Increased occurrence of anti-AQP4 seropositivity and unique HLA Class II associations with neuromyelitis optica (NMO), among Muslim Arabs in Israel

T. Ben-Hur, D. Karussis, M. Mandel, 2016, Journal of Neuroimmunology.

Immunomodulation of experimental autoimmune myasthenia gravis with linomide

D. Karussis, D. Lehmann, O. Abramsky, 1994, Journal of Neuroimmunology.

Myasthenia gravis-associated neuromyelitis optica-like disease: an immunological link between the central nervous system and muscle?

T. Ben-Hur, D. Karussis, O. Abramsky, 2011, Archives of neurology.

Multiple sclerosis in diverse populations: characteristics in distinct Arab ethnicities in Israel

I. Lavi, Ariel Miller, D. Karussis, 2012, Multiple sclerosis.

Mesenchymal stem cells (MSC) derived from mice with experimental autoimmune encephalomyelitis (EAE) suppress EAE and have similar biological properties with MSC from healthy donors.

D. Karussis, I. Kassis, P. Petrou, 2013, Immunology letters.